May 22 2022

Classification of the active ingredient bendroflumethiazide

Risk level in pregnancy: This medicine is classified as Category Category D in pregnancy-induced hypertension.

Update 18.07.2009

Meaning of category D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.